By Professor Adam Jaffe

Books

Smith MD; Crace EJ; Jaffe A; Karunadasa HI, 2018, The Diversity of Layered Halide Perovskites, http://dx.doi.org/10.1146/annurev-matsci-070317-124406

Gray M, 2017, Asthma first aid management in schools, Gray M; Burns C; Jaffe A, (eds.), Apple iTunes Store

Bush A, 2006, Cystic Fibrosis in the 21st Century, Bush A; Alton EWFW; Davies JC; Griesenbach U; Jaffe A, (eds.), Karger Medical and Scientific Publishers

Book Chapters

Pabary R; Jaffe A; Bush A, 2024, 'Macrolides and Cystic Fibrosis', in Progress in Inflammation Research, pp. 59 - 92, http://dx.doi.org/10.1007/978-3-031-42859-3_4

THEOCHAROUS K; Hameed S; Verge C; Jaffe A; Prentice B, 2021, 'Detection and management of early glucose abnormalities in cystic fibrosis', in Cystic Fibrosis - Facts, Management and Advances, IntechOpen, http://dx.doi.org/10.5772/intechopen.92847

Homaira N; Jaffe A, 2021, 'Pleural Effusion, Necrotizing Pneumonia and Long-Term Morbidity of Respiratory Infection in Childhood', in Encyclopedia of Respiratory Medicine Second Edition, pp. 132 - 145, http://dx.doi.org/10.1016/B978-0-08-102723-3.00025-1

Prentice B; Jaffe A, 2019, 'Diseases of the pleural space', in Wimott RW; Deterding R; Li A; Ratjen F; Sly P; Zar HH; Bush A (ed.), Kendig's Disorders of the Respiratory Tract in Children, Elsevier

Saddi V; Ooi KC; Jaffe A, 2018, 'Cystic Fibrosis', in Rudolph's Pediatrics, 23rd Edition, McGraw-Hill Education / Medical, https://accesspediatrics.mhmedical.com/content.aspx?bookid=2126&sectionid=190246234

Prentice B; Jaffé A, 2018, '69 - Air and Fluid in the Pleural Space', in Kendig's Disorders of the Respiratory Tract in Children, pp. 1007 - 1026.e3, http://dx.doi.org/10.1016/B978-0-323-44887-1.00069-9

Smith MD; Crace EJ; Jaffe A; Karunadasa HI, 2018, 'The Diversity of Layered Halide Perovskites', in Clarke DR (ed.), ANNUAL REVIEW OF MATERIALS RESEARCH, VOL 48, ANNUAL REVIEWS, pp. 111 - 136, http://dx.doi.org/10.1146/annurev-matsci-070317-124406

Prentice B; Jaffe A; Thomas PS, 2016, 'Anti-asthma Drugs, Overview', in Compendium of Inflammatory Diseases, Springer Basel, pp. 64 - 69, http://dx.doi.org/10.1007/978-3-7643-8550-7_6

Prentice B; Jaffe A; Thomas PS, 2016, 'Antimuscarinics', in Compendium of Inflammatory Diseases, Springer Basel, pp. 101 - 105, http://dx.doi.org/10.1007/978-3-7643-8550-7_49

Prentice B; Jaffe A; Thomas PS, 2016, 'Beta2 Receptor Agonists', in Compendium of Inflammatory Diseases, Springer Basel, pp. 210 - 214, http://dx.doi.org/10.1007/978-3-7643-8550-7_17

Prentice B; Jaffe A; Thomas PS, 2016, 'Beta2 Receptor Agonists', in Encyclopedia of Inflammatory Diseases, Springer Basel, pp. 1 - 6, http://dx.doi.org/10.1007/978-3-0348-0620-6_17-2

Prentice B; Jaffe A; Thomas PS, 2016, 'Chromones: Cromoglycate and Nedocromil', in Compendium of Inflammatory Diseases, Springer Basel, pp. 330 - 332, http://dx.doi.org/10.1007/978-3-7643-8550-7_63

Prentice B; Jaffe A; Thomas PS, 2016, 'Theophylline', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1252 - 1254, http://dx.doi.org/10.1007/978-3-7643-8550-7_53

Prentice B; Jaffe A, 2015, 'Anti-asthma drugs, overview', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_6-1

Prentice B; Jaffe A; Thomas P, 2015, 'Anti-muscurinics', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_49-1

Prentice B; Jaffe A; Thomas P, 2015, 'Beta₂ agonists', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_17-1

Prentice B; Jaffe A; Thomas P, 2015, 'Chromones - Cromoglycate and nedocromil', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_63-1

Prentice B; Jaffe A; Thomas P, 2015, 'Theophylline', in Parnham M (ed.), Encyclopedia of Inflammatory Diseases, Springer Reference, http://dx.doi.org/10.1007/978-3-0348-0620-6_53-1

Jaffe A, 2012, 'Asthma', in South M; Isaacs D (ed.), Practical Paediatrics, Elsevier, London, pp. 482 - 490

Ives A; Dixon M; Shoemark A; Jaffe A; Hogg C, 2009, 'Primary ciliary dyskinesia', in Haver K; Brigger MT; Hardy SC; Hartnick CJ (ed.), Pediatric Aerodigestive Disorders, Pleural Publishing Inc, San Diego, pp. 353 - 376

Urquhart DS; Montgomery H; Jaffe A, 2008, 'Assessment, definition and treatment of hypoxia in children`s with cystic fibrosis', in Yearbook Respiratory Care Clinics and Applied Technologies, World Federation of Respiratory Care and Applied Technologies, pp. 769 - 773

Sonnappa S; Jaffe A, 2008, 'Management techniques in childhood empyema', in Yearbook Respiratory Care Clinics and Applied Technologies, World Federation of Respiratory Care and Applied Technologies, pp. 439 - 442

Gringas G; Jaffe A; Sheldon S, 2007, 'ADHD and sleep disorders', in Taylor E (ed.), People with Hyperactivity Understanding and Managing Their Problems, Mac Keith Press, pp. 160 - 169

Jaffe A; Barker P, 2007, 'Basic science - what will it deliver: non gene therapy treatments', in Hodson ME; Geddes D; Bush A (ed.), Cystic Fibrosis, Hodder Arnold, pp. 463 - 469

Jaffe A; Bush A, 2005, 'Macrolides in cystic fibrosis', in Rubin BK; Tamaoki J (ed.), Antibiotics as anti-inflammatory and immunomodulatory agents, Birkhauser Publishing, Basel

Jaffe A; Baraldi E, 2005, 'Non-invasive measurements of inflammation in asthma', in Dinwiddie R; Brand PLP (ed.), Paediatric Asthma and Allergy, Quay Books, Wiltshire, United Kingdom

Bush A; Griesenbach U; Davies JC; Alton EWFW; Jaffe A, 2005, 'The Future', in Progress in Respiratory Research, KARGER, pp. 316 - 322, http://dx.doi.org/10.1159/000088618

Jaffe A; Bush A, 2003, 'Cystic Fibrosis', in Medicines for Children

Journal articles

Braithwaite J; Fisher G; Harrison R; Mumford V; Davis EA; de Wet C; Homaira N; Mitchell R; Jaffe A; Willcock S; McMullan B; Arnolda G; Zurynski Y; Woodhead H; Goodger B; White L; Elias L; Vir S; Durrington L; Smith M; Fraser L; Swann J; Flynn A; Massis C; Benson I; Vickery T; Corbett H; Rojas C; Hibbert P, 2025, 'The National Paediatric Applied Research Translation Initiative (N-PARTI): using implementation science to improve primary care for Australian children with asthma, type 1 diabetes, and infections', BMC Health Services Research, 25, http://dx.doi.org/10.1186/s12913-025-12491-5

Bhurawala H; Jaffe A, 2025, 'Australasian Bronchiolitis PREDICT Guideline 2025: Evidence-Based Recommendations for Equity and Care Across Diverse Settings.', J Paediatr Child Health, http://dx.doi.org/10.1111/jpc.70142

Dayaratne WLN; Torres-Cadena R; Walte AF; Wan S; Morales Campos J; Jaffe A, 2025, 'A Hybrid Bronze Age: Progress and Potential in Mixed-Valence Organic-Inorganic Metal Oxides', Inorganic Chemistry, 64, pp. 12881 - 12899, http://dx.doi.org/10.1021/acs.inorgchem.5c01018

Hameed S; Barnes EH; Briody J; Wainwright CE; Hilton J; Field PI; Tai A; Belessis Y; Chan CL; Selvadurai H; Prentice B; Katz T; McMahon SK; Neylan M; Pena A; Jaffe A; Verge CF, 2025, 'Insulin for early glycaemic abnormality in children with cystic fibrosis without cystic fibrosis-related diabetes (CF-IDEA): a randomised controlled trial', Lancet Child and Adolescent Health, 9, pp. 371 - 382, http://dx.doi.org/10.1016/S2352-4642(25)00099-9

Ozturk A; Chan M; Khan JR; Hu N; McMullan B; Britton PN; Bartlett A; Kandasamy R; Saravanos GL; Prentice B; Shi T; Jaffe A; Owens L; Homaira N, 2025, 'Clinical Characteristics and In-hospital Outcomes Associated with Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 Years', Journal of Infectious Diseases, 231, pp. 1309 - 1317, http://dx.doi.org/10.1093/infdis/jiae543

Palmer EE; Recsei K; McKnight L; Roberts N; Baynam G; Zurynski Y; Farrar M; Healy L; Millis N; Jaffe A, 2025, '“You get left behind and lost in a complex world of rare care”: equity in access to rare disease care—learnings from the Australian Rare Disease Awareness, Education, Support, and Training (RArEST) project', Ebiomedicine, 115, http://dx.doi.org/10.1016/j.ebiom.2025.105710

Fathima P; Pan E; Marsh J; Newall N; Meares T; McLeod C; Shanthikumar S; Jaffe A; Tai A; Ward N; Sivam S; Selvadurai H; Schultz A; Snelling T, 2025, 'BEAT-CF (Bayesian Evidence Adaptive Treatment for people with Cystic Fibrosis): description of a prospective cohort for nested studies in cystic fibrosis', Respiratory Medicine, 241, http://dx.doi.org/10.1016/j.rmed.2025.108080

Chan C; Coffey M; Murphy C; McKay I; Abdu J; Paida K; Tam RY; Wrigley-Carr H; Prentice B; Owens L; Belessis Y; Chuang S; Jaffe A; van Dorst J; Ooi CY, 2025, 'The Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis', Microorganisms, 13, http://dx.doi.org/10.3390/microorganisms13030681

Fawcett LK; Waters SA; Jaffe A, 2025, 'The equitable challenges to quality use of modulators for cystic fibrosis in Australia', Medical Journal of Australia, 222, pp. 4 - 9, http://dx.doi.org/10.5694/mja2.52527

Torres-Cadena R; Dayaratne WLN; Chen HT; Kovrigin EL; Tucker MG; Haberl B; Jaffe A, 2025, 'Negative Compressibility Transitions in Hybrid Metal Oxides', Journal of the American Chemical Society, http://dx.doi.org/10.1021/jacs.5c08464

Mackle R; Chan M; Lay M; Purcell M; Campbell N; Jaffe A; Owens L; Gray M; Homaira N, 2025, 'Parental perceptions and knowledge toward Asthma Action Plans', Journal of Asthma, 62, pp. 435 - 444, http://dx.doi.org/10.1080/02770903.2024.2408758

Råket HK; Milder T; Litchfield M; Jensen CB; Wang JN; Jimenez-Solem E; Petersen J; Pearson SA; Jaffe A; Falster MO, 2025, 'Reduced Use of Maintenance Therapies Among People With Cystic Fibrosis Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor in Australia', Clinical Therapeutics, http://dx.doi.org/10.1016/j.clinthera.2025.05.016

Homaira N; Khan JR; Jaffé A, 2025, 'Serotype 3 associated invasive pneumococcal disease in children: Analysis of 15 years of Australian national surveillance data', Thorax, http://dx.doi.org/10.1136/thorax-2025-223125

Rashid MM; Hu N; Khan JR; Chan M; Gray M; Owens L; Jaffe A; Homaira N, 2025, 'The High Burden of Asthma Readmission Among Australian Children: A Population-Based Cohort Study', Respirology, http://dx.doi.org/10.1111/resp.70049

Coffey MJ; van Dorst J; Pushpakumara BU; Hudson J; Halim J; Day AS; Oliver M; Ranganathan S; Wainwright C; Selvadurai H; Thomas T; Jaffe A; Ooi CY, 2025, 'WS19.06 Probiotics and the EARly Life effects on intestinal bacteria and inflammation in children with Cystic Fibrosis (PEARL-CF) Study', Journal of Cystic Fibrosis, 24, pp. S35 - S36, http://dx.doi.org/10.1016/j.jcf.2025.03.676

Khan JR; Lingam R; Owens L; Chen K; Shanthikumar S; Oo S; Schultz A; Widger J; Bakar KS; Jaffe A; Homaira N, 2024, 'Social deprivation and spatial clustering of childhood asthma in Australia', Global Health Research and Policy, 9, http://dx.doi.org/10.1186/s41256-024-00361-2

Doumit M; Pacey V; Jaffe A; Gray K, 2024, 'Understanding the acceptability of the changing model of care in cystic fibrosis', Respiratory Medicine, 234, http://dx.doi.org/10.1016/j.rmed.2024.107847

McKnight L; Schultz A; Vidic N; Palmer EE; Jaffe A, 2024, 'Learning to make a difference for chILD: Value creation through network collaboration and team science', Pediatric Pulmonology, 59, pp. 2257 - 2266, http://dx.doi.org/10.1002/ppul.26377

Walte AF; Torres-Cadena R; Dayaratne WLN; Jaffe A, 2024, 'Mixed-Metal Alloying in Hybrid Bronzes', Journal of the American Chemical Society, 146, pp. 23699 - 23703, http://dx.doi.org/10.1021/jacs.4c08960

Back to profile page